Stempeutics Research Pvt Ltd
Best Stem Cell Therapeutics Development Company 2020
Stempeutics Research Bangalore is a late stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells.
Company’s flagship product - Stempeucel® is a Phase III ready, allogeneic, cultured, pooled, off-the-shelf, bone marrow derived mesenchymal stromal cell (“MSC”) product. Stempeucel® is being developed for the treatment of Critical Limb Ischemia, Osteoarthritis and non-healing Diabetic Foot Ulcer. Stempeucel® is the FIRST innovative stem cell based biological product to get conditional marketing approval by DCGI (Indian FDA) for the treatment of Critical Limb Ischemia due to Buerger’s disease. Currently Phase 4/PMS study is in progress in India. Stempeutics is seeking partners for further clinical development and commercialization of Stempeucel® in US/Europe/Japan.
MD & CEO
Stempeutics Research, Bangalore, India